CStone Pharmaceuticals (CSPHF)
USD 0.52
(61.37%)
USD 0.52
(61.37%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -534.6 Million CNY | 35.77% |
| 2022 | -832.27 Million CNY | 55.08% |
| 2021 | -1.85 Billion CNY | -51.6% |
| 2020 | -1.22 Billion CNY | 21.66% |
| 2019 | -1.56 Billion CNY | -69.28% |
| 2018 | -921.6 Million CNY | -243.32% |
| 2017 | -268.44 Million CNY | -8.51% |
| 2016 | -247.38 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | -48.63 Million USD | 0.0% |
| 2023 Q2 | -36.64 Million USD | 0.0% |
| 2023 FY | -534.6 Million CNY | 35.77% |
| 2022 FY | -832.27 Million CNY | 55.08% |
| 2022 Q4 | -76.61 Million USD | 0.0% |
| 2022 Q2 | -58.26 Million USD | 0.0% |
| 2021 FY | -1.85 Billion CNY | -51.6% |
| 2021 Q2 | -116.22 Million USD | 0.0% |
| 2021 Q4 | -167.18 Million USD | 0.0% |
| 2020 Q4 | -52.9 Million USD | 0.0% |
| 2020 Q2 | -104.41 Million USD | 0.0% |
| 2020 FY | -1.22 Billion CNY | 21.66% |
| 2019 Q4 | -169.42 Million USD | 0.0% |
| 2019 FY | -1.56 Billion CNY | -69.28% |
| 2019 Q2 | -81.58 Million USD | 0.0% |
| 2018 Q3 | 132.67 Million CNY | 0.0% |
| 2018 FY | -921.6 Million CNY | -243.32% |
| 2018 Q4 | -577.94 Million CNY | -535.6% |
| 2017 Q4 | -55.49 Million CNY | 0.0% |
| 2017 FY | -268.44 Million CNY | -8.51% |
| 2016 FY | -247.38 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Qrons Inc. | -643.67 Thousand USD | -82955.166% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 753.139% |
| Nascent Biotech, Inc. | -2.22 Million USD | -23874.709% |
| Adynxx, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -3268.72% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -42464.252% |
| BioStem Technologies, Inc. | -7.77 Million USD | -6772.466% |
| CSL Limited | 3.7 Billion USD | 114.441% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -10497.855% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -2895.501% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -863.117% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -77723.277% |
| Skye Bioscience, Inc. | -13.67 Million USD | -3810.29% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -128572.448% |
| Rebus Holdings, Inc. | -664 Thousand USD | -80413.102% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -39932.544% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -137130.023% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -644.723% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 10977.468% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -204162.091% |
| SQZ Biotechnologies Company | -75.82 Million USD | -605.054% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -18654.804% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -34704.033% |
| Mesoblast Limited | -84.14 Million USD | -535.325% |
| Marizyme, Inc. | -34.08 Million USD | -1468.383% |
| Genus plc | 6.4 Million USD | 8453.234% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 5587.393% |
| Pharming Group N.V. | -4.87 Million USD | -10856.085% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -26812.291% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -57299.45% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -6302.479% |
| ContraFect Corporation | -56.88 Million USD | -839.737% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -11637.413% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -38031.985% |
| IMV Inc. | -38.67 Million USD | -1282.431% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -19334.325% |
| MultiCell Technologies, Inc. | -722.81 USD | -73962213.748% |
| ONE Bio Corp. | 13.68 Million USD | 4007.503% |
| Accustem Sciences Inc. | -3.74 Million USD | -14169.813% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -806.267% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -110570.473% |
| Q BioMed Inc. | -3.44 Million USD | -15415.571% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 15201.893% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -20246.433% |
| Biomind Labs Inc. | -1 Million USD | -52852.2% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -872.502% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -18326.782% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -7941.603% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -28574.941% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -1784779.14% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -27562.436% |
| GB Sciences, Inc. | -1.42 Million USD | -37534.89% |
| Alpha Cognition Inc. | -9.7 Million USD | -5408.232% |
| HST Global, Inc. | -140.9 Thousand USD | -379304.146% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -47424.593% |
| Halberd Corporation | -75.05 Thousand USD | -712234.444% |
| Enzolytics Inc. | -2.14 Million USD | -24779.328% |
| Agentix Corp. | -1.37 Million USD | -38872.456% |
| Resverlogix Corp. | -12.74 Million USD | -4093.325% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -16773.762% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | -25.775% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -51107.567% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -18211.946% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -33749.704% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -15600.743% |
| AVAX Technologies, Inc. | 6.69 Million USD | 8087.697% |
| Zenith Capital Corp. | -8.94 Million USD | -5877.938% |
| Genscript Biotech Corporation | -415.79 Million USD | -28.576% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -3068650.359% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -21673.441% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -311606.859% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -26566.923% |
| Kadimastem Ltd | -3.04 Million USD | -17484.311% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -54227.054% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -294473.656% |
| LadRx Corporation | -3.82 Million USD | -13881.676% |
| Cell Source, Inc. | -4.32 Million USD | -12259.867% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -77723.277% |
| NovAccess Global Inc. | -2.46 Million USD | -21572.437% |
| Affymax, Inc. | -15.04 Million USD | -3453.15% |
| Itoco Inc. | -919.14 Thousand USD | -58063.827% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -12513.374% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -47675.424% |
| Mobile Lads Corp. | -554.55 Thousand USD | -96303.751% |
| CytoDyn Inc. | -18.05 Million USD | -2860.5% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -2123884.903% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -242817.057% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -94567.12% |
| SYBLEU INC | -149.18 Thousand USD | -358263.722% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -29333.525% |
| International Stem Cell Corporation | -663 Thousand USD | -80534.54% |
| Bioxytran, Inc. | -3.82 Million USD | -13894.409% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1015490.805% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -2628252.999% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -1374.127% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -32941.224% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -72553.108% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -17084.41% |
| Neutra Corp. | -229.48 Thousand USD | -232858.438% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2948.104% |
| PureTech Health plc | -146.19 Million USD | -265.671% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -2387.572% |
| IXICO plc | -1.43 Million USD | -37102.992% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -5532.778% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -338.9% |
| CSL Limited | 3.81 Billion USD | 114.024% |
| Cellectis S.A. | -108.85 Million USD | -391.108% |